These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 2406450)
1. Tumor hypoxia, drug resistance, and metastases. Brown JM J Natl Cancer Inst; 1990 Mar; 82(5):338-9. PubMed ID: 2406450 [No Abstract] [Full Text] [Related]
2. Effects of reoxygenation on cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential. Young SD; Hill RP J Natl Cancer Inst; 1990 Mar; 82(5):371-80. PubMed ID: 2304086 [TBL] [Abstract][Full Text] [Related]
3. Hypoxia and drug resistance. Teicher BA Cancer Metastasis Rev; 1994 Jun; 13(2):139-68. PubMed ID: 7923547 [TBL] [Abstract][Full Text] [Related]
4. The evolution of biologic diversity in metastases. Fidler IJ; Talmadge JE Transplant Proc; 1984 Apr; 16(2):370-2. PubMed ID: 6719543 [No Abstract] [Full Text] [Related]
5. Physiologic mechanisms of therapeutic resistance. Blood flow and hypoxia. Teicher BA Hematol Oncol Clin North Am; 1995 Apr; 9(2):475-506. PubMed ID: 7642474 [TBL] [Abstract][Full Text] [Related]
6. An added dimension: will three-dimensional cultures improve our understanding of drug resistance? Steeg PS; Alley MC; Grever MR J Natl Cancer Inst; 1994 Jul; 86(13):953-5. PubMed ID: 8007014 [No Abstract] [Full Text] [Related]
7. Hypoxia and metastasis. Chaudary N; Hill RP Clin Cancer Res; 2007 Apr; 13(7):1947-9. PubMed ID: 17404073 [No Abstract] [Full Text] [Related]
8. Metastases and drug-resistance as markers of cancer cell evolution. Poupon MF AIDS Res Hum Retroviruses; 1992 May; 8(5):796-806. PubMed ID: 1515230 [No Abstract] [Full Text] [Related]
9. Heterogeneity in growth pattern and drug sensitivity of primary tumor and metastases in the human tumor colony-forming assay. Schlag P; Schreml W Cancer Res; 1982 Oct; 42(10):4086-9. PubMed ID: 7105006 [TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance. Fine RL; Chabner BA Cancer Chemother Biol Response Modif; 1987; 9():81-92. PubMed ID: 2908588 [No Abstract] [Full Text] [Related]
12. Biology of a brain metastasis. Walsh JW Neurosurg Clin N Am; 1996 Jul; 7(3):369-76. PubMed ID: 8823769 [TBL] [Abstract][Full Text] [Related]
13. Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling. Frederiksen LJ; Sullivan R; Maxwell LR; Macdonald-Goodfellow SK; Adams MA; Bennett BM; Siemens DR; Graham CH Clin Cancer Res; 2007 Apr; 13(7):2199-206. PubMed ID: 17404104 [TBL] [Abstract][Full Text] [Related]
15. Link between tumor progression, proteases, and cell motility. Pathology B workshop. Muschel RJ; Tykocinski M; Padarathsingh M Am J Pathol; 1996 Sep; 149(3):1073-6. PubMed ID: 8780409 [No Abstract] [Full Text] [Related]
17. Resistance to cytostatic drugs at the cellular level. Vendrik CP; Bergers JJ; De Jong WH; Steerenberg PA Cancer Chemother Pharmacol; 1992; 29(6):413-29. PubMed ID: 1568284 [No Abstract] [Full Text] [Related]
18. [Recent progress in the study of the mechanism of resistance to DNA topoisomerase inhibitors]. Ishida R; Andoh T Gan To Kagaku Ryoho; 1994 Jun; 21(7):952-61. PubMed ID: 8002633 [TBL] [Abstract][Full Text] [Related]